AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Total Current Liabilities (2020 - 2026)

Updated

AbCellera Biologics (ABCL) posted Total Current Liabilities of $53.19 million for Q2 2026, down 20.6% from $67.02 million a year earlier but up 12.5% from the prior quarter.

Analysis

AbCellera Biologics (ABCL) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, AbCellera Biologics' Total Current Liabilities came in at $64.31 million, down 16.1% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
  • In prior years, AbCellera Biologics' Total Current Liabilities was $76.61 million in FY2024 (-35.6%), $119.01 million in FY2023 (+0.6%), $118.32 million in FY2022 (-2.0%) and $120.68 million in FY2021 (+16.6%).
  • Quarterly Total Current Liabilities has run from a low of $47.29 million in Q1 2026 to a high of $221.14 million in Q2 2022 over five years.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last nine quarters, with an average decline of 23.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2022, with growth of 217.0%; the weakest was Q1 2023, with a decline of 58.0%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $47.29 million (Q1 2026), $64.31 million (Q4 2025) and $68.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 54.90 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 41.64 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -31.55 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 3.94 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn - 53.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.19 Mn
Mar 31, 2026 47.29 Mn
Dec 31, 2025 64.31 Mn
Sep 30, 2025 68.80 Mn
Jun 30, 2025 67.02 Mn
Mar 31, 2025 75.40 Mn
Dec 31, 2024 76.61 Mn
Sep 30, 2024 79.57 Mn
Jun 30, 2024 70.38 Mn
Mar 31, 2024 104.88 Mn
Dec 31, 2023 119.01 Mn
Sep 30, 2023 110.24 Mn
Jun 30, 2023 118.91 Mn
Mar 31, 2023 89.59 Mn
Dec 31, 2022 118.32 Mn
Sep 30, 2022 106.05 Mn
Jun 30, 2022 221.14 Mn
Mar 31, 2022 213.42 Mn
Dec 31, 2021 120.68 Mn
Sep 30, 2021 49.55 Mn
API Access

AbCellera Biologics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABCL&period=max&api_key=YOUR_API_KEY